PT Itama Ranoraya Tbk 2023 AR2
The report highlights PT Itama Ranoraya Tbk's performance and sustainability initiatives for the fiscal year 2023. The company recorded net sales of IDR 696.3 billion and a net profit of IDR 5.2 billion, driven by its focus on medical device distribution. Key achievements include receiving the TOP Good Corporate Governance Award 2023 from The Iconomics and expanding strategic partnerships with principals like Mindray. On the sustainability front, the company conducted various community empowerment programs, including blood donations and product training for vaccine refrigerators, while maintaining zero workplace accidents over the past three years.
Company: PT Itama Ranoraya Tbk
Sector: Health Care
Country: Indonesia
Year: 2023
Type: AR2
Pages: 327
PT Itama Ranoraya Tbk
Annual Report
The report highlights PT Itama Ranoraya Tbk's performance and sustainability initiatives for the fiscal year 2023. The company recorded net sales of IDR 696.3 billion and a net profit of IDR 5.2 billion, driven by its focus on medical device distribution. Key achievements include receiving the TOP Good Corporate Governance Award 2023 from The Iconomics and expanding strategic partnerships with principals like Mindray. On the sustainability front, the company conducted various community empowerment programs, including blood donations and product training for vaccine refrigerators, while maintaining zero workplace accidents over the past three years.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Total Waste
Workplace Fatalities
Employees